Skip to content
Clinical Trials – home
Sanofi Winthrop Industrie
Sponsor

Sanofi Winthrop Industrie

France 14 Espace Henry Vallee, 69007 Lyon, France

About the sponsor

Sanofi Winthrop Industrie supports clinical research in glycogen storage disease type II, with attention to Pompe disease and long-term patient follow-up in France.

  • Avalglucosidase alfa
  • Post-trial access
  • Long-term safety

The sponsor’s activity in this area is centered on ongoing care pathways for patients who have completed earlier treatment studies.

About Specializations

Sanofi Winthrop Industrie runs clinical trials in conditions such as Niemann-Pick disease, Meningococcal immunisation, Glycogen storage disease type II, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Sponsor:Sanofi Winthrop Industrie
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:TETANUS TOXOID
  • Sponsor:Sanofi Winthrop Industrie
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Avalglucosidase Alfa
  • Sponsor:Sanofi Winthrop Industrie

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).